Michael Orme

3.1k total citations
79 papers, 2.4k citations indexed

About

Michael Orme is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Michael Orme has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 20 papers in Public Health, Environmental and Occupational Health and 18 papers in Pharmacology. Recurrent topics in Michael Orme's work include Pharmacogenetics and Drug Metabolism (19 papers), Reproductive Health and Contraception (17 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Michael Orme is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Reproductive Health and Contraception (17 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Michael Orme collaborates with scholars based in United Kingdom, United States and Sweden. Michael Orme's co-authors include David Back, AM Breckenridge, A Breckenridge, P.H. Rowe, D.J. Back, Francesca E. Crawford, A Breckenridge, Gunnar Alván, Leif Bertilsson and R. Sibeon and has published in prestigious journals such as Diabetes, American Journal of Obstetrics and Gynecology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael Orme

78 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Orme United Kingdom 28 727 670 492 425 385 79 2.4k
M. Orme United Kingdom 24 429 0.6× 657 1.0× 408 0.8× 224 0.5× 240 0.6× 55 1.7k
L.A. Salako Nigeria 30 1.4k 2.0× 466 0.7× 325 0.7× 182 0.4× 161 0.4× 118 2.6k
A Breckenridge United Kingdom 21 313 0.4× 479 0.7× 214 0.4× 265 0.6× 188 0.5× 43 1.9k
Evan J. Begg New Zealand 40 832 1.1× 549 0.8× 816 1.7× 1.3k 3.0× 144 0.4× 145 4.5k
Robert A. Blouin United States 29 291 0.4× 769 1.1× 478 1.0× 582 1.4× 153 0.4× 119 2.8k
Gillian M. Shenfield Australia 28 183 0.3× 380 0.6× 322 0.7× 349 0.8× 216 0.6× 114 2.3k
D.J. Back United Kingdom 29 629 0.9× 615 0.9× 475 1.0× 197 0.5× 346 0.9× 80 2.2k
David J. Tiller Australia 32 479 0.7× 393 0.6× 384 0.8× 179 0.4× 295 0.8× 106 4.1k
Mario L. Rocci United States 24 140 0.2× 466 0.7× 322 0.7× 360 0.8× 218 0.6× 73 2.1k
Peter H. Vlasses United States 28 323 0.4× 261 0.4× 307 0.6× 359 0.8× 255 0.7× 176 2.9k

Countries citing papers authored by Michael Orme

Since Specialization
Citations

This map shows the geographic impact of Michael Orme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Orme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Orme more than expected).

Fields of papers citing papers by Michael Orme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Orme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Orme. The network helps show where Michael Orme may publish in the future.

Co-authorship network of co-authors of Michael Orme

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Orme. A scholar is included among the top collaborators of Michael Orme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Orme. Michael Orme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orme, Michael & Folke Sjöqvist. (2013). Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries. European Journal of Clinical Pharmacology. 69(9). 1635–1639. 6 indexed citations
2.
Orme, Michael. (2013). Efforts and success world-wide in the field of clinical pharmacology. European Journal of Clinical Pharmacology. 69(S1). 3–9. 2 indexed citations
3.
Orme, Michael, Donald Birkett, Kim Brøsen, et al.. (2010). Clinical Pharmacology in Research, Teaching and Health Care. Basic & Clinical Pharmacology & Toxicology. 107(1). 531–559. 78 indexed citations
4.
Cooper, Simon & Michael Orme. (2006). Road traffic law. Oxford University Press eBooks. 3 indexed citations
5.
Butterworth, Tony, et al.. (2004). StLaR HR Plan Project. Phase II Strategic Report. Developing and sustaining a world class workforce of educators and researchers in health and social care.A report to the Strategic Learning and Research Committee (StLaR) containing an account of present circumstances and suggested recommendations, leading to a Human Resource Plan for educators and researchers in health and social care.. 1 indexed citations
6.
Orme, Michael. (2002). The Erice Statement on drug advertising to consumers.. PubMed. 58(8). S106–8. 1 indexed citations
7.
Orme, Michael. (1999). Postgraduate education and training: challenges for the future. Hospital Medicine. 60(11). 829–831.
8.
Grimmer, S.F.M., David Back, Michael Orme, et al.. (1992). The in‐vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac disease. Alimentary Pharmacology & Therapeutics. 6(1). 79–85. 4 indexed citations
9.
Orme, Michael. (1991). Animal Toxicity Studies: Their Relevance for Man. British Journal of Clinical Pharmacology. 31(4). 494. 28 indexed citations
10.
Back, D.J., et al.. (1991). Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes. The Journal of Steroid Biochemistry and Molecular Biology. 38(2). 219–225. 45 indexed citations
11.
Orme, Michael, D.J. Back, & S. Ball. (1989). Interindividual variation in the metabolism of ethynylestradiol. Pharmacology & Therapeutics. 43(2). 251–260. 32 indexed citations
12.
Orme, Michael, et al.. (1989). The teaching of clinical pharmacology in Europe and North America. Trends in Pharmacological Sciences. 10(6). 224–226. 8 indexed citations
13.
Winstanley, PA & Michael Orme. (1988). WHICH ADVERSE DRUG INTERACTIONS ARE REALLY IMPORTANT?. Adverse Drug Reaction Bulletin. 130(1). 488–491. 1 indexed citations
14.
Back, D.J., et al.. (1987). Comparative pharmacokinetics of levonqrgestrel and ethinyloestradiol following intravenous, oral and vaginal administration. Contraception. 36(4). 471–479. 32 indexed citations
15.
Orme, Michael. (1985). The Relationship between the Plasma Concentration of Non-Steroidal Anti-Inflammatory Drugs and Their Therapeutic Effects. Birkhäuser Basel eBooks. 17. 151–155. 10 indexed citations
16.
17.
Back, David, AM Breckenridge, Francesca E. Crawford, et al.. (1980). The effect of rifampicin oh the pharmacokinetics of ethynylestradiol in women. Contraception. 21(2). 135–143. 66 indexed citations
18.
Baber, N., L. Halliday, W.J.A. van den Heuvel, et al.. (1979). Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders. Annals of the Rheumatic Diseases. 38(2). 128–136. 59 indexed citations
19.
Back, David, AM Breckenridge, Francesca E. Crawford, et al.. (1978). First-pass effect of norethindrone in rabbits and rats.. Journal of Pharmacology and Experimental Therapeutics. 207(2). 555–565. 23 indexed citations
20.
Breckenridge, A, C. W. BURKE, D. S. Davies, & Michael Orme. (1973). Immediate decrease by hydrocortisone of the plasma half‐life of antipyrine. British Journal of Pharmacology. 47(2). 434–436. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Orme Breakdown of academic impact, for papers by L.A. Salako Breakdown of academic impact, for papers by A Breckenridge Breakdown of academic impact, for papers by Evan J. Begg Breakdown of academic impact, for papers by Robert A. Blouin Breakdown of academic impact, for papers by Gillian M. Shenfield Breakdown of academic impact, for papers by D.J. Back Breakdown of academic impact, for papers by David J. Tiller Breakdown of academic impact, for papers by Mario L. Rocci Breakdown of academic impact, for papers by Peter H. Vlasses
Rankless by CCL
2026